524703 — Sandu Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹583.23m
- IN₹571.78m
- IN₹672.81m
- 68
- 41
- 37
- 46
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 15.4 | 117 | 41.7 | 23 | 12.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 46.8 | 53.5 | 39.9 | 47.9 | 48.7 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 224 | 305 | 236 | 255 | 223 |
Net Property, Plant And Equipment | 165 | 161 | 164 | 170 | 178 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 414 | 470 | 493 | 542 | 524 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 113 | 125 | 119 | 139 | 106 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 122 | 135 | 128 | 149 | 118 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 292 | 335 | 365 | 392 | 406 |
Total Liabilities & Shareholders' Equity | 414 | 470 | 493 | 542 | 524 |
Total Common Shares Outstanding |